☆ 4.7 Meeting Abstract

Image-based risk score to predict recurrence of ER plus breast cancer in ECOG-ACRIN Cancer Research Group E2197.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 36, Issue 15, Pages -

Publisher

AMER SOC CLINICAL ONCOLOGY

DOI: 10.1200/JCO.2018.36.15_suppl.540

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Oncology

E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group

Roisin M. Connolly, Fengmin Zhao, Kathy D. Miller, Min-Jung Lee, Richard L. Piekarz, Karen L. Smith, Ursa A. Brown-Glaberman, Jennifer S. Winn, Bryan A. Faller, Adedayo A. Onitilo, Mark E. Burkard, George T. Budd, Ellis G. Levine, Melanie E. Royce, Peter A. Kaufman, Alexandra Thomas, Jane B. Trepel, Antonio C. Wolff, Joseph A. Sparano

Summary: The combination of entinostat and exemestane did not improve survival in patients with AI-resistant advanced HR-positive, HER2-negative breast cancer. E2112 phase III trial: no benefit seen in adding HDAC inhibitor entinostat to exemestane in advanced breast cancer.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Quality control for digital tomosynthesis in the ECOG-ACRIN EA1151 TMIST trial

Aili K. Maki, Gordon E. Mawdsley, James G. Mainprize, Etta D. Pisano, Sam Z. Shen, Olivier Alonzo-Proulx, Martin J. Yaffe

Summary: This study aims to evaluate the effectiveness of digital breast tomosynthesis (TM) compared to digital mammography (DM) for breast cancer screening and establish a quality control (QC) program to ensure proper operation of the equipment. The results showed that most systems performed consistently, but universal threshold or target metrics were not applicable to all machine types. Deviations relative to baseline values were more useful. Quality monitoring of the database was based on data from the headers of the patient images.

MEDICAL PHYSICS (2023)

Add to Collection

Article Oncology

A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)

Angela R. Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty, Benjamin A. Herman, Susan M. Domchek, Angela M. DeMichele, Kara N. Maxwell, Adedayo A. Onitilo, Shamsuddin Virani, SuJung Park, Bryan A. Faller, Stefan C. Grant, Ryan C. Ramaekers, Robert J. Behrens, Gopakumar S. Nambudiri, Ruth C. Carlos, Lynne I. Wagner

Summary: This study found that patients who received genetic education before tumor genetic sequencing had increased understanding and reduced distress, particularly in women. However, the effects were not significant in men and patients with lower health literacy.

CANCER (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701)

Michael A. Boss, Bradley S. Snyder, Eunhee Kim, Dena Flamini, Sarah Englander, Karthik M. Sundaram, Naveen Gumpeni, Suzanne L. Palmer, Haesun Choi, Adam T. Froemming, Thorsten Persigehl, Matthew S. Davenport, Dariya Malyarenko, Thomas L. Chenevert, Mark A. Rosen

Summary: The study evaluated the repeatability and reproducibility of whole-prostate and focal-lesion ADC assessment in a multi-site setting. Results showed good repeatability and reproducibility for whole-prostate median pixel ADC, and high interreader reliability for focal lesion ADC.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2022)

Add to Collection

Article Oncology

The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials

Eric Vachon, Ellen Krueger, Victoria L. Champion, David A. Haggstrom, David Cella, Andrea A. Cohee

Summary: The study examines the relationship between fear of cancer recurrence (FCR) and healthcare utilization among young and older breast cancer survivors. Young survivors have higher FCR, which is significantly associated with all three types of breast cancer-related utilization. Increased FCR is associated with hypervigilance among survivors and may lead to increased healthcare utilization.

PSYCHO-ONCOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

Shinn-Huey S. Chou, Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth Carlos, Sunil S. Badve, Jennifer Xiao, Ralph L. Corsetti, Sara H. Javid, Derrick W. Spell, Linda K. Han, Jennifer L. Sabol, John R. Bumberry, Ilana F. Gareen, Bradley S. Snyder, Constantine Gatsonis, Lynne Wagner, Antonio C. Wolff, Kathy D. Miller, Joseph A. Sparano, Christopher E. Comstock, Habib Rahbar

Summary: This study analyzed MRI features of DCIS patients in the ECOG-ACRIN E4112 trial, finding that most DCIS cases showed nonmass enhancement on MRI scans and that MRI could increase the additional cancer detection rate. However, MRI features were not predictive of pathological or genomic outcomes for DCIS.

RADIOLOGY (2021)

Add to Collection

Article Oncology

Copy number heterogeneity identifies ER plus breast cancer patients that do not benefit from adjuvant endocrine therapy

Tom van den Bosch, Oscar M. Rueda, Carlos Caldas, Louis Vermeulen, Daniel M. Miedema

Summary: This study found that low-risk breast cancer patients identified using chromosomal copy-number ITH do not benefit from adjuvant endocrine therapy.

BRITISH JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)

M. Margaret Kemeny, Fengmin Zhao, Arlene A. Forastiere, Paul Catalano, Stanley R. Hamilton, Brent W. Miedema, Nancy A. Dawson, Louis M. Weiner, Brian D. Smith, Bernard A. Mason, Stephen L. Graziano, Paul B. Gilman, Alan P. Venook, Harlan A. Pinto, Robert P. Whitehead, Peter J. O'Dwyer, Al B. Benson

Summary: This phase III trial evaluated the effect of perioperative chemotherapy on overall survival for colon cancer patients. The results showed no significant difference in survival rates and disease-free survival between patients who received perioperative chemotherapy and those who did not, regardless of their stage.

ANNALS OF SURGICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors

Seodhna M. Lynch, Niamh M. Russell, Stephen Barron, Chan-Ju A. Wang, Tony Loughman, Peter Dynoodt, Bozena Fender, Cesar Lopez-Ruiz, Anthony O'Grady, Katherine M. Sheehan, Joanna Fay, Verena Amberger-Murphy, Anurati Saha, Rut Klinger, Claudia A. Gonzalez, Nebras Al-Attar, Arman Rahman, Desmond O'Leary, Fiona T. Lanigan, Adrian P. Bracken, John Crown, Catherine M. Kelly, Darran P. O'Connor, William M. Gallagher

Summary: The study assessed the prognostic performance of a 6-gene molecular score and a composite risk score against four routinely used molecular and clinicopathological risk assessment tools. Results showed that both scores were significantly prognostic for distant recurrence-free survival and invasive disease-free survival, providing additional prognostic information to other risk factors/tools assessed. The 6-gene signature demonstrated superior risk stratification and increased prognosis reliability for treatment decisions.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

Robert L. Ferris, Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J. Garcia, Christine H. Chung, Maura L. Gillison, Umamaheswar Duvvuri, Bert W. O'Malley, Enver Ozer, Giovana R. Thomas, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Nabil F. Saba, Miriam Lango, Eduardo Mendez, Barbara Burtness

Summary: This study aimed to investigate the efficacy and safety of primary transoral surgery (TOS) and reduced postoperative radiation therapy (RT) in intermediate-risk patients with human papillomavirus-associated oropharynx cancer (HPV+ OPC). The results showed that TOS and reduced RT achieved favorable oncologic outcomes and functional outcomes in intermediate-risk HPV+ OPC patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Microcalcifications and Peritumoral Edema Predict Survival Outcome in Luminal Breast Cancer Treated with Neoadjuvant Chemotherapy

Bo Ra Kwon, Sung Ui Shin, Soo-Yeon Kim, Yunhee Choi, Nariya Cho, Sun Mi Kim, Ann Yi, Bo La Yun, Mijung Jang, Su Min Ha, Su Hyun Lee, Jung Min Chang, Woo Kyung Moon

Summary: This study identified MRI features and clinical-pathologic variables associated with prolonged survival in patients with luminal breast cancer treated with neoadjuvant chemotherapy. The prediction model showed good discrimination ability and stratified prognosis into low-risk and high-risk groups. These findings contribute to the understanding and assessment of patient outcomes.

RADIOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)

Soudabeh Fazeli, Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff, Constantine A. Gatsonis, Ralph L. Corsetti, Habib Rahbar, Derrick W. Spell, Kenneth B. Blankstein, Linda K. Han, Jennifer L. Sabol, John R. Bumberry, Kathy D. Miller, Joseph A. Sparano, Christopher E. Comstock, Lynne Wagner, Ruth C. Carlos

Summary: This study found that patient preferences and receipt of surgery for DCIS were influenced by MRI results and surgeon recommendations. These findings emphasize the importance of ensuring adequate information and ongoing communication about the clinical significance of MRI findings and the benefits and risks of available treatment options.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Medicine, General & Internal

Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)

Soudabeh Fazeli, Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff, Constantine A. Gatsonis, Kathy D. Miller, Joseph A. Sparano, Christopher E. Comstock, Lynne Wagner, Ruth C. Carlos

Summary: This study found that women with DCIS undergoing breast MRI experience a significant testing burden, which is significantly associated with cancer worry. Understanding the potential reduction in quality of life associated with MRI, especially when used in combination with mammography, may help in developing targeted interventions to improve the patient experience.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Oncology

The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group (EA) trials

Angela Wangari Walter, Ju-Whei Lee, Joanna M. Streck, Ilana F. Gareen, Benjamin A. Herman, Sheetal M. Kircher, Ruth C. Carlos, Shaji K. Kumar, Ingrid A. Mayer, Nabil F. Saba, Timothy S. Fenske, Joel W. Neal, Michael B. Atkins, Frank S. Hodi, Christos E. Kyriakopoulos, Clare M. Tempany-Afdhal, Tait D. Shanafelt, Lynne I. Wagner, Stephanie R. Land, Jamie S. Ostroff, Elyse R. Park

Summary: Neighborhood socioeconomic disadvantage is associated with smoking and less cessation support among patients diagnosed with cancer. It is important to provide increased cessation support for patients from disadvantaged neighborhoods.

CANCER (2023)

Add to Collection

Article Oncology

Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2-Breast Cancer

Ran Song, Dong-Eun Lee, Eun-Gyeong Lee, Seeyoun Lee, Han-Sung Kang, Jai Hong Han, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Youngmee Kwon, Jaeyeon Woo, So-Youn Jung

Summary: This retrospective study identified clinicopathological factors that can predict the Oncotype DX (ODX) risk group in early breast cancer patients, providing alternative options to the costly and time-consuming ODX test. The factors predicting the ODX risk group differ according to age, and can help guide decision-making on adjuvant chemotherapy.

CANCERS (2023)

Add to Collection

Article Oncology

Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome

Ruiwen Ding, Prateek Prasanna, German Corredor, Cristian Barrera, Philipp Zens, Cheng Lu, Priya Velu, Patrick Leo, Niha Beig, Haojia Li, Paula Toro, Sabina Berezowska, Vipul Baxi, David Balli, Merzu Belete, David L. Rimm, Vamsidhar Velcheti, Kurt Schalper, Anant Madabhushi

Summary: This study reveals the spatial differences in tumor-infiltrating lymphocytes (TILs) between lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC). TIL density is prognostic of overall survival in LUAD, while spatial arrangement is more prognostically relevant in LUSC. The TIL signature specific to LUAD is associated with overall survival and response to therapy. In both subtypes, TIL features are associated with immune scores and biological pathways related to immune recognition, response, and evasion.

NPJ PRECISION ONCOLOGY (2022)

Add to Collection

Article Oncology

Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation

Sara Arabyarmohammadi, Patrick Leo, Vidya Sankar Viswanathan, Andrew Janowczyk, German Corredor, Pingfu Fu, Howard Meyerson, Leland Metheny, Anant Madabhushi

Summary: Computer-extracted morphology and texture features from chromatin patterns of myeloblasts can predict post-HCT relapse and prognosticate RFS in patients with AML/MDS.

JCO CLINICAL CANCER INFORMATICS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Integrating Radiomics With Clinicoradiological Scoring Can Predict High-Risk Patients Who Need Surgery in Crohn's Disease: A Pilot Study

Prathyush Chirra, Anamay Sharma, Kaustav Bera, H. Matthew Cohn, Jacob A. Kurowski, Katelin Amann, Marco-Jose Rivero, Anant Madabhushi, Cheng Lu, Rajmohan Paspulati, Sharon L. Stein, Jeffrey A. Katz, Satish E. Viswanath, Maneesh Dave

Summary: Radiomic features extracted from magnetic resonance enterography are associated with the need for surgery in Crohn's disease patients at risk of complications, and when combined with clinical variables and radiological assessment, they can accurately predict the time to surgery.

INFLAMMATORY BOWEL DISEASES (2023)

Add to Collection

Article Oncology

Automated analysis of computerized morphological features of cell clusters associated with malignancy on bile duct brushing whole slide images

Shayan Monabbati, Patrick Leo, Kaustav Bera, Claire W. Michael, Behtash G. Nezami, Aparna Harbhajanka, Anant Madabhushi

Summary: This study used computational image analysis to predict the presence of pancreatic and biliary tract adenocarcinoma on digitized brush cytology specimens. By extracting nuclear morphological and texture features and training machine learning classifiers, the researchers successfully improved the sensitivity and specificity of diagnosis.

CANCER MEDICINE (2023)

Add to Collection

Article Computer Science, Artificial Intelligence

Multi-site cross-organ calibrated deep learning (MuSClD): Automated diagnosis of non-melanoma skin cancer

Yufei Zhou, Can Koyuncu, Cheng Lu, Rainer Grobholz, Ian Katz, Anant Madabhushi, Andrew Janowczyk

Summary: Deep learning performs well in computational pathology tasks but struggles with domain shift on whole slide images generated at external test sites. To address this, researchers propose using off-target organs from the test site for calibration, effectively mitigating the domain shift and improving the robustness of the model for skin cancer classification.

MEDICAL IMAGE ANALYSIS (2023)

Add to Collection

Article Oncology

Nondestructive 3D pathology with analysis of nuclear features for prostate cancer risk assessment

Robert Serafin, Can Koyuncu, Weisi Xie, Hongyi Huang, Adam K. Glaser, Nicholas P. Reder, Andrew Janowczyk, Lawrence D. True, Anant Madabhushi, Jonathan T. C. Liu

Summary: Previous studies have shown that computational analysis of 2D histology images can improve prognostication of prostate cancer outcomes. This study expands on previous work by exploring the prognostic value of 3D shape-based nuclear features in prostate cancer. The results suggest that these features are associated with cancer aggressiveness and could be valuable for decision-support tools.

JOURNAL OF PATHOLOGY (2023)

Add to Collection

Review Oncology

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group

Jeppe Thagaard, Glenn Broeckx, David B. Page, Chowdhury Arif Jahangir, Sara Verbandt, Zuzana Kos, Rajarsi Gupta, Reena Khiroya, Khalid Abduljabbar, Gabriela Acosta Haab, Balazs Acs, Guray Akturk, Jonas S. Almeida, Isabel Alvarado-Cabrero, Mohamed Amgad, Farid Azmoudeh-Ardalan, Sunil Badve, Nurkhairul Bariyah Baharun, Eva Balslev, Enrique R. Bellolio, Vydehi Bheemaraju, Kim R. M. Blenman, Luciana Botinelly Mendonca Fujimoto, Najat Bouchmaa, Octavio Burgues, Alexandros Chardas, Maggie U. Cheang, Francesco Ciompi, Lee A. D. Cooper, An Coosemans, German Corredor, Anders B. Dahl, Flavio Luis Dantas Portela, Frederik Deman, Sandra Demaria, Johan Dore Hansen, Sarah N. Dudgeon, Thomas Ebstrup, Mahmoud Elghazawy, Claudio Fernandez-Martin, Stephen B. Fox, William M. Gallagher, Jennifer M. Giltnane, Sacha Gnjatic, Paula Gonzalez-Ericsson, Anita Grigoriadis, Niels Halama, Matthew G. Hanna, Aparna Harbhajanka, Steven N. Hart, Johan Hartman, Soren Hauberg, Stephen Hewitt, Akira Hida, Hugo M. Horlings, Zaheed Husain, Evangelos Hytopoulos, Sheeba Irshad, Emiel A. M. Janssen, Mohamed Kahila, Tatsuki R. Kataoka, Kosuke Kawaguchi, Durga Kharidehal, Andrey Khramtsov, Umay Kiraz, Pawan Kirtani, Liudmila L. Kodach, Konstanty Korski, Aniko Kovacs, Anne-Vibeke Laenkholm, Corinna Lang-Schwarz, Denis Larsimont, Jochen K. Lennerz, Marvin Lerousseau, Xiaoxian Li, Amy Ly, Anant Madabhushi, Sai K. Maley, Vidya Manur Narasimhamurthy, Douglas K. Marks, Elizabeth S. McDonald, Ravi Mehrotra, Stefan Michiels, Fayyaz ul Amir Afsar Minhas, Shachi Mittal, David A. Moore, Shamim Mushtaq, Hussain Nighat, Thomas Papathomas, Frederique Penault-Llorca, Rashindrie D. Perera, Christopher J. Pinard, Juan Carlos Pinto-Cardenas, Giancarlo Pruneri, Lajos Pusztai, Arman Rahman, Nasir Mahmood Rajpoot, Bernardo Leon Rapoport, Tilman T. Rau, Jorge S. Reis-Filho, Joana M. Ribeiro, David Rimm, Anne Roslind, Anne Vincent-Salomon, Manuel Salto-Tellez, Joel Saltz, Shahin Sayed, Ely Scott, Kalliopi P. Siziopikou, Christos Sotiriou, Albrecht Stenzinger, Maher A. Sughayer, Daniel Sur, Susan Fineberg, Fraser Symmans, Sunao Tanaka, Timothy Taxter, Sabine Tejpar, Jonas Teuwen, E. Aubrey Thompson, Trine Tramm, William T. Tran, Jeroen van Der Laak, Paul J. van Diest, Gregory E. Verghese, Giuseppe Viale, Michael Vieth, Noorul Wahab, Thomas Walter, Yannick Waumans, Hannah Y. Wen, Wentao Yang, Yinyin Yuan, Reena Md Zin, Sylvia Adams, John Bartlett, Sibylle Loibl, Carsten Denkert, Peter Savas, Sherene Loi, Roberto Salgado, Elisabeth Specht Stovgaard

Summary: The clinical significance of tumor-immune interaction in breast cancer has been established. Tumor-infiltrating lymphocytes (TILs) have emerged as predictive and prognostic biomarkers for patients with triple-negative and HER2-positive breast cancer. The use of machine learning (ML) to automatically evaluate TILs has shown promising results. However, there are challenges in implementing this in trial and routine clinical management, including technical slide issues, ML and image analysis aspects, data challenges, and validation issues.

JOURNAL OF PATHOLOGY (2023)

Add to Collection

Review Oncology

Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

David B. Page, Glenn Broeckx, Chowdhury Arif Jahangir, Chowdhury Jahangir, Sara Verbandt, Rajarsi R. Gupta, Jeppe Thagaard, Reena Khiroya, Zuzana Kos, Khalid Abduljabbar, Gabriela Acosta Haab, Balazs Acs, Jonas S. Almeida, Isabel Alvarado-Cabrero, Farid Azmoudeh-Ardalan, Sunil Badve, Nurkhairul Bariyah Baharun, Enrique R. Bellolio, Vydehi Bheemaraju, Kim R. M. Blenman, Luciana Botinelly Mendonca Fujimoto, Octavio Burgues, Maggie Chon U. Cheang, Francesco Ciompi, Lee A. D. Cooper, An Coosemans, German Corredor, Flavio Luis Dantas Portela, Frederik Deman, Sandra Demaria, Sarah N. Dudgeon, Mahmoud Elghazawy, Scott Ely, Claudio Fernandez-Martin, Susan Fineberg, Stephen B. Fox, William M. Gallagher, Jennifer M. Giltnane, Sacha Gnjatic, Paula Gonzalez-Ericsson, Anita Grigoriadis, Niels Halama, Matthew G. Hanna, Aparna Harbhajanka, Alexandros Hardas, Steven N. Hart, Johan Hartman, Stephen Hewitt, Akira Hida, Hugo M. Horlings, Zaheed Husain, Evangelos Hytopoulos, Sheeba Irshad, Emiel A. M. Janssen, Mohamed Kahila, Tatsuki R. Kataoka, Kosuke Kawaguchi, Durga Kharidehal, Andrey Khramtsov, Umay Kiraz, Pawan Kirtani, Liudmila L. Kodach, Konstanty Korski, Aniko Kovacs, Anne-Vibeke Laenkholm, Corinna Lang-Schwarz, Denis Larsimont, Jochen K. Lennerz, Marvin Lerousseau, Xiaoxian Li, Amy Ly, Anant Madabhushi, Sai K. Maley, Vidya Manur Narasimhamurthy, Douglas K. Marks, Elizabeth S. McDonald, Ravi Mehrotra, Stefan Michiels, Fayyaz ul Amir Afsar Minhas, Shachi Mittal, David A. Moore, Shamim Mushtaq, Hussain Nighat, Thomas Papathomas, Frederique Penault-Llorca, Rashindrie D. Perera, Christopher J. Pinard, Juan Carlos Pinto-Cardenas, Giancarlo Pruneri, Lajos Pusztai, Arman Rahman, Nasir Mahmood Rajpoot, Bernardo Leon Rapoport, Tilman T. Rau, Jorge S. Reis-Filho, Joana M. Ribeiro, David Rimm, Anne-Vincent Salomon, Manuel Salto-Tellez, Joel Saltz, Shahin Sayed, Kalliopi P. Siziopikou, Christos Sotiriou, Albrecht Stenzinger, Maher A. Sughayer, Daniel Sur, Fraser Symmans, Sunao Tanaka, Timothy Taxter, Sabine Tejpar, Jonas Teuwen, E. Aubrey Thompson, Trine Tramm, William T. Tran, Jeroen van Der Laak, Paul J. van Diest, Gregory E. Verghese, Giuseppe Viale, Michael Vieth, Noorul Wahab, Thomas Walter, Yannick Waumans, Hannah Y. Wen, Wentao Yang, Yinyin Yuan, Sylvia Adams, John Mark Seaverns Bartlett, Sibylle Loibl, Carsten Denkert, Peter Savas, Sherene Loi, Roberto Salgado, Elisabeth Specht Stovgaard, Guray Akturk, Najat Bouchmaa

Summary: Modern histologic imaging platforms combined with machine learning methods offer new opportunities for studying the spatial distribution of immune cells in the tumor microenvironment. However, there is currently no standardized method for describing or analyzing spatial immune cell data, and most previous spatial analyses have been simplistic. In this review, two approaches (raster versus vector-based) for reporting and analyzing spatial data are outlined, along with a summary of reported spatial immune cell metrics and their prognostic associations in various cancers. Two well-described clinical biomarkers, the breast cancer stromal tumor infiltrating lymphocytes score and the colon cancer Immunoscore, are also discussed, along with potential research opportunities to improve the clinical utility of these spatial biomarkers.

JOURNAL OF PATHOLOGY (2023)

Add to Collection

Article Oncology

Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings

Abhishek Midya, Amogh Hiremath, Jacob Huber, Vidya Sankar Viswanathan, Danly Omil-Lima, Amr Mahran, Leonardo K. Bittencourt, Sree Harsha Tirumani, Lee Ponsky, Rakesh Shiradkar, Anant Madabhushi

Summary: The objective of this study was to quantify radiomic changes in prostate cancer progression on serial MRI among patients on active surveillance and evaluate their association with pathologic progression on biopsy. The study found that delta radiomics were more strongly associated with upgrade events compared to other clinical variables, and the combination of delta radiomics with baseline clinical variables showed the strongest association with biopsy upgrade prediction.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Oncology

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer

Mohammadhadi Khorrami, Vidya Sakar Viswanathan, Priyanka Reddy, Nathaniel Braman, Siddharth Kunte, Amit Gupta, Jame Abraham, Alberto J. Montero, Anant Madabhushi

Summary: Imaging texture biomarkers before and after CDK4/6i therapy can predict early response and overall survival in MBC patients with liver metastases. Radiomic features can predict a lack of response earlier than standard anatomic/RECIST 1.1 assessment, highlighting the need for further study and clinical validation.

NPJ BREAST CANCER (2023)

Add to Collection

Article Pathology

Identifying primary tumor site of origin for liver metastases via a combination of handcrafted and deep learning features

Chuheng Chen, Cheng Lu, Vidya Viswanathan, Brandon Maveal, Bhunesh Maheshwari, Joseph Willis, Anant Madabhushi

Summary: This study uses computer-extracted histomorphometric features to identify the primary site of origin for liver metastases. It found that features related to nuclear and peri-nuclear shape were the most important in classifying different metastatic tumors. Additionally, attention maps generated by a deep learning network can provide a composite feature similarity heat map between primary tumors and their associated metastases.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2023)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Automatic myeloblast segmentation in acute myeloid leukemia images based on adversarial feature learning

Zelin Zhang, Sara Arabyarmohammadi, Patrick Leo, Howard Meyerson, Leland Metheny, Jun Xu, Anant Madabhushi

Summary: This article introduces a segmentation model based on conditional generative adversarial network for efficient segmentation of myeloblasts from slides of AML patients. Through validation experiments, it is confirmed that this method has better segmentation performance than other deep learning models, and prognostic models for predicting the risk of recurrence in AML patients have been constructed using the segmentation results.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2024)

Add to Collection

Article Urology & Nephrology

Clinical Relevance of Computationally Derived Attributes of Peritubular Capillaries from Kidney Biopsies

Yijiang Chen, Jarcy Zee, Andrew R. Janowczyk, Jeremy Rubin, Paula Toro, Kyle J. Lafata, Laura H. Mariani, Lawrence B. Holzman, Jeffrey B. Hodgin, Anant Madabhushi, Laura Barisoni

Summary: Computational image analysis enables quantification of PTC attributes and the discovery of a previously unrecognized PTC biomarker (aspect ratio) associated with clinical outcome.

KIDNEY360 (2023)

Add to Collection

Article Oncology

Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study

Sukanya Iyer, Marwa Ismail, Benita Tamrazi, Ralph Salloum, Peter de Blank, Ashley Margol, Ramon Correa, Jonathan Chen, Kaustav Bera, Volodymyr Statsevych, Mai-Lan Ho, Pranjal Vaidya, Ruchika Verma, Debra Hawes, Alexander Judkins, Pingfu Fu, Anant Madabhushi, Pallavi Tiwari

Summary: This study found that aggressive medulloblastoma tumors can induce pronounced local structural deformations in the surrounding brain parenchyma. Additionally, these local deformations are independently associated with molecular subgroups and overall survival in medulloblastoma patients. Combining the local deformation statistics with current risk stratification approaches can lead to more reliable risk assessment in pediatric medulloblastoma.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Meeting Abstract Ophthalmology

OCT-derived SubRPE Compartment Radiomics Features are Associated with the Development of Subfoveal Geographic Atrophy

Sudeshna Sil Kar, Hasan Cetin, Joseph Abraham, Sunil K. Srivastava, Anant Madabhushi, Justis P. Ehlers

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.